AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2011
May 6, 2011
34705_dirs_2011-05-06_43738483-1f0a-4686-85b0-3cfb1ea9bdb0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2011-04-18
Reporting Person: SHENOY SUDHAKAR V (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-18 | ESOP (right to buy) | $0.56 | A | 175000 | Acquired | 2016-04-17 | Common Stock (175000) | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15